Health
Study: Anti-microRNA drug significantly reduces miR-92a levels in human peripheral blood – News-Medical.Net
A single intravenous dose of MRG-110, an anti-microRNA drug, significantly reduced miR-92a levels in the blood of healthy humans.
A single intravenous dose of MRG-110, an anti-microRNA drug, significantly reduced miR-92a levels in the blood of healthy humans.
Inhibition of miR-92a has shown beneficial effects in animal models, including improved vascularization after myocardial infarction, and accelerated wound healing, according to the peer-reviewed journal Nucleic Acid Therapeutics.
“Based on documented, promising therapeutic potential, locked nucleic acid (LNA)-based anti-miR-92a was further developed and tested in a …
-
General16 hours agoVictorian school teacher charged with soliciting child abuse material
-
Business24 hours agoHere’s what analysts expect for the BHP share price in the coming year
-
General8 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
Noosa News22 hours agoBrisbane news LIVE updates: University gains Olympic scholarships